Sign In
Buy INO
$1.14
-0.0700 (-5.79%)
At Close: Jun 03, 2026
FDA Lifts Partial Clinical Hold On Inovio's Phase 2 Investigational Coronavirus Vaccine Study
08:24am, Monday, 16'th Nov 2020
Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are higher after an update issued by the company on its investigational coronavirus vaccine. What Happened: Pennsylvania-based Inovio said the FDA has
At This Point, Go Ahead and Count Inovio Pharmaceuticals Out of the Vaccine Race
08:19am, Monday, 16'th Nov 2020
INO stock is a purely speculative bet. I don't see the company being among the few that deliver a vaccine against Covid-19.
Better Coronavirus Stock: Inovio Pharmaceuticals or Regeneron?
04:23am, Saturday, 14'th Nov 2020
These companies are capitalizing on the market's interest in combating the coronavirus.
Is the Options Market Predicting a Spike in Inovio (INO) Stock?
08:35am, Thursday, 12'th Nov 2020
Investors need to pay close attention to Inovio (INO) stock based on the movements in the options market lately.
Can Inovio Benefit From All Of Its Vaccine Delays?
10:51am, Wednesday, 11'th Nov 2020
Shares of Inovio (NASDAQ:INO) are trading near a six-month low. The company is being battered by delays in getting its Covid-19 vaccine candidate into Phase 2 trials.
Should Inovio Be On Your Buy List As It Tackles A Coronavirus Vaccine?
08:00am, Wednesday, 11'th Nov 2020
Inovio has thrown its hat into the coronavirus vaccine ring with big biopharma names like Moderna, Johnson & Johnson and Pfizer. But INO stock is volatile on its vaccine news.
How to Invest in the Coronavirus Vaccine Race Right Now
06:53am, Wednesday, 11'th Nov 2020
Pfizer grabbed the spotlight when it released efficacy data from its phase 3 study earlier this week. But is it too late to get in on the action?
5 Reasons Chasing COVID-19 Vaccine Stocks Is a Bad Idea
06:06am, Wednesday, 11'th Nov 2020
Investors are setting themselves up for disappointment.
Exclusive: Editor-in-Chief Of The Lancet On Coronavirus Vaccines And The Pandemic
05:55am, Wednesday, 11'th Nov 2020
Richard Horton, author of The COVID-19 Catastrophe, shares his insights about what a vaccine would mean for the world and how the globe responded to the pandemic.
Here's how millennials traded stocks on the Pfizer news
11:59am, Tuesday, 10'th Nov 2020
Millennials were taking profits on the travel stock rise while doubling down on the stay-at-home stocks. CNBC's Kate Rooney reports.
What Really Mattered With Inovio's Q3 Update
06:08am, Tuesday, 10'th Nov 2020
Hint: It wasn't the company's top and bottom lines.
Inovio Pharmaceuticals, Inc. (INO) CEO J. Joseph Kim on Q3 2020 Results - Earnings Call Transcript
11:34pm, Monday, 09'th Nov 2020
Inovio Pharmaceuticals, Inc. (INO) CEO J. Joseph Kim on Q3 2020 Results - Earnings Call Transcript
Recap: Inovio Pharmaceuticals Q3 Earnings
04:53pm, Monday, 09'th Nov 2020
Shares of Inovio Pharmaceuticals (NASDAQ:INO) increased 2.94% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share fell 4.00% year over year to ($0.26),
INOVIO Reports Third Quarter 2020 Financial Results
04:05pm, Monday, 09'th Nov 2020
PLYMOUTH MEETING, Pa., Nov. 9, 2020 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from
Inovio Plunges To 7-Month Low On Updates From Rival COVID-19 Vaccine Developers
11:15am, Monday, 09'th Nov 2020
Coronavirus vaccine developer Inovio Pharmaceuticals Inc (NASDAQ: INO)'s stock, which was rocked in September by the partial clinical hold imposed on the planned Phase 2/3 study of the company's DNA
